Figure 5From: Simvastatin prevents alveolar bone loss in an experimental rat model of periodontitis after ovariectomy Analysis of bone formation and resorption serum biochemical markers after simvastatin treatment. (A) Changes in the serum levels of the bone formation marker osteocalcin (OCN) are shown after 2 months of simvastatin or saline treatment. (B) Changes in the serum levels of the bone resorption marker tartrate-resistant acid phosphatase 5b (TRAP5b) are shown after 2 months of simvastatin or saline treatment. Values are expressed as the mean the standard deviation (N = 6; * indicates p < 0.05, ** indicates p < 0.01).Back to article page